Reduction of alloantibody response to class I major histocompatibility complex by targeting synthetic allopeptides for presentation by B cells

Transplantation

Volumn 63, Issue 7, 1997, Pages 926-932

  MacDonald, Catherine M ^a   Bolton, Eleanor M ^a,b   Jaques, Bryon C ^a   Walker, Kenneth G ^a   Bradley, J Andrew ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b WESTERN INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; CD4 ANTIGEN; FREUND ADJUVANT; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN G; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ALPHA HELIX; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; BLOOD TRANSFUSION; CELL POLARITY; HEART GRAFT; HELPER CELL; IMMUNOLOGICAL TOLERANCE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGEN-PRESENTING CELLS; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; HEART TRANSPLANTATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; IMMUNE TOLERANCE; IMMUNOGLOBULIN FAB FRAGMENTS; ISOANTIBODIES; MALE; PEPTIDE FRAGMENTS; RATS; RECOMBINANT PROTEINS; TRANSPLANTATION IMMUNOLOGY;

EID: 0030935714     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199704150-00003     Document Type: Article

References (34)

1. Lechler RI, Lombardi G, Batchelor JR, Reinsmoen N, Bach FH. The molecular basis of alloreactivity. Immunol Today 1990; 11: 83.
2. Sherman LA, Chattopadhyay S. The molecular basis of allorecognition. Annu Rev Immunol 1993; 11: 385.
3. Sayegh MH, Warschinger B, Carpenter CB. Mechanisms of T cell recognition of alloantigen: the role of peptides. Transplantation 1994; 57: 1295.
4. Dalchau R, Fangmann J, Fabre JW. Allorecognition of isolated denatured chains of class I and class II MHC molecules: evidence for an important role for indirect allorecognition in transplantation. Eur J Immunol 1992; 22: 669.
5. Benichou G, Takizawa PA, Olson CA, McMillan M, Sercarz EE. Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection. J Exp Med 1992; 125: 305.
6. Fangmann J, Dalchau R, Fabre JW. Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides. J Exp Med 1992; 175: 1521.
7. Lechler RI, Batchelor JR. Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells. J Exp Med 1982; 155: 31.
8. Braun MY, McCormack A, Webb G, Batchelor JR. Mediation of acute but not chronic rejection of MHC-incompatible rat kidney grafts by alloreactive CD4 T cells activated by the direct pathway of sensitization. Transplantation 1993; 55: 177.
9. Sawyer GJ, Dalchau R, Fabre JW. Indirect T cell allorecognition: a cyclosporin A resistant pathway for T cell help for antibody production to donor MHC antigens. Transplant Immunol 1993; 1: 77.
10. Auchincloss H, Lee R, Shea S. The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class II deficient mice. Proc Natl Acad Sci USA 1993; 90: 3373.
11. Shoskes DA, Wood KJ. Indirect presentation of MHC antigens in transplantation. Immunol Today 1994; 15: 32.
12. Bradley JA, Mowat AM, Bolton EM. Processed MHC class I alloantigen as the stimulus for CD4 T cell dependent antibody-mediated graft rejection. Immunol Today 1992; 13: 434.
13. Gracie JA, Bolton EM, Porteous C, Bradley JA. The T cell requirements for the rejection of renal allografts bearing an isolated class I MHC disparity. J Exp Med 1990; 172: 1547.
14. Morton AL, Bell EB, Bolton EM, et al. CD4+ T cell-mediated rejection of major histocompatibility complex class I-disparate grafts: a role for alloantibody. Eur J Immunol 1993; 23: 2078.
15. Kelly C, Benham AM, Sawyer GJ, Dalchau R, Fabre JW. A three-cell cluster hypothesis for noncognate T-B collaboration via direct T cell recognition of allogeneic dendritic cells. Transplantation 1996; 61: 1094.
16. Steele DJR, Laufer TM, Smiley ST, et al. Two levels of help for B cell alloantibody production. J Exp Med 1996; 183: 699.
17. + T cells and B cell responses after cardiac allograft rejection. Transplantation 1995; 59: 401.
18. Fuchs EJ, Matzinger P. B cells turn off virgin but not memory T cells. Science 1992; 258: 1156.
19. Eynon EE, Parker DC. Small B cells as antigen presenting cells in the induction of tolerance to soluble protein antigens. J Exp Med 1992; 175: 131.
20. Eynon EE, Parker DC. Parameters of tolerance induction by antigen targeted to B lymphocytes. J Immunol 1993; 151: 2958.
21. Chen C, Nabavi N. In vitro induction of T cell anergy by blocking B7 and early T cell costimulatory molecule ETC-1/B7-2. Immunity 1994; 1: 147.
22. Buhlmann J, Foy T, Aruffo A, et al. In the absence of CD40 signal, B cells are tolerogenic. Immunity 1995; 2: 645.
23. Day MJ, Tse AGD, Puklavec M, Simmonds SJ, Mason DW. Targeting autoantigen to B cells prevents the induction of a cell-mediated autoimmune disease in rats. J Exp Med 1992; 175: 655.
24. Rada C, Lorenzi R, Powis SJ, van den Bogaerde J, Parham P, Howard JC. Concerted evolution of class I genes in the major histocompatibility complex of murine rodents. Proc Natl Acad Sci USA 1990; 87: 2167.
25. Ono K, Lindsey S. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 1969; 57: 225.
26. Whitby EH, Sparshott SM, Bell EB. Allograft rejection in athymic nude rats by transferred T-cell subsets. Immunology 1990; 69: 78.
27. Gracie JA, Bradley JA. Interleukin-12 induces interferon-γ-dependent switching of IgG alloantibody subclasses. Eur J Immunol 1996; 26: 1217.
28. Tweedle JR, Middleton SE, Marshall HE, Bradley JA, Bolton EM. Alloantibody and intragraft cellular response to MHC class I-disparate kidney allografts in recipients tolerized by DST and cyclosporin. Transplantation 1996; 62: 23.
29. Salgar S, Kunz HW, Gill TJ. Nucleotide sequence and structural analysis of the rat RT1.Eu and RT1.Aw3 genes, and of genes related to RT1.O and RT1.C. Immunogenetics 1995; 42: 244.
30. Rudensky A, Preston-Hurlburt P, Hong SC, Barlow A, Janeway CA. Sequence analysis of peptides bound to MHC class II molecules. Nature 1991; 353: 622.
31. Chicz RM, Urban RG, Lane WS, et al. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature 1992; 358: 764.
32. Terness P, Dufter C, Otto G, Opelz G. Allograft survival following immunization with membrane-bound or soluble peptide MHC class I donor antigens: factors relevant for the induction of rejection by indirect recognition. Transpl Int 1996; 9: 2.
33. Svetic A, Finkelman FD, Jian YC, et al. Cytokine gene expression after in vivo primary immunization with goat antibody to mouse IgD antibody. J Immunol 1991; 147: 2391.
34. Saudi A, Simmonds S, Huitinga I, Mason D. Prevention of experimental allergic encephalomyelitis in rats by targeting autoantigen to B cells: evidence that the protective mechanism depends on changes in the cytokine response and migratory properties of the autoantigen-specific T cells. J Exp Med 1995; 58: 335.